KCTD13 antibody
Principal name
KCTD13 antibody
Alternative names for KCTD13 antibody
KCTD13, PDIP1, POLDIP1, BTB/POZ domain-containing protein KCTD13, Polymerase delta-interacting protein 1, TNFAIP1-like protein
Ncbi ID
NP_849194, 9606, NP_849194.1, NM_178863, NP_766335.1, NM_172747
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P), Enzyme Immunoassay (E)
Background of KCTD13 antibody
- Kit Component:
- - KN206944G1, KCTD13 gRNA vector 1 in pCas-Guide vector
- KN206944G2, KCTD13 gRNA vector 2 in pCas-Guide vector
- KN206944D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
He,H., et al., (2001) Proc. Natl. Acad. Sci. U.S.A. 98 (21), 11979-11984
Human Brain; KCTD13 antibody - N-terminal region (ARP35522_P050) in Human Brain cells using Immunohistochemistry
Human heart; WB Suggested Anti-KCTD13 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human heart; KCTD13 antibody - N-terminal region (ARP35522_P050) in Human heart cells using Western Blot
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-KCTD13 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3 min, TA808801)(1:150)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-KCTD13 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3 min, TA808801)(1:150)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KCTD13 (RC206944, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KCTD13.(1:2000)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KCTD13 (RC206944, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KCTD13.(1:2000)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KCTD13 (RC206944, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KCTD13.(1:2000)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KCTD13 (RC206944, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KCTD13.(1:2000)
WB Suggested Anti-KCTD13 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Human heart
Human Brain
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA808801 | KCTD13 antibody |
||||||
| KCTD13 mouse monoclonal antibody, clone OTI3B12 (formerly 3B12) | |||||||
 |
Mouse | IgG1 | OTI3B12 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|
||||||
| TA808802 | KCTD13 antibody |
||||||
| KCTD13 mouse monoclonal antibody, clone OTI1A4 (formerly 1A4) | |||||||
 |
Mouse | IgG1 | OTI1A4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA808803 | KCTD13 antibody |
||||||
| KCTD13 mouse monoclonal antibody, clone OTI7D5 (formerly 7D5) | |||||||
 |
Mouse | IgG1 | OTI7D5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA808833 | KCTD13 antibody |
||||||
| KCTD13 mouse monoclonal antibody, clone OTI3B5 (formerly 3B5) | |||||||
 |
Mouse | IgG2b | OTI3B5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP760326 | KCTD13 (full length, N-term HIS tag) |
||||
| Purified recombinant protein of Homo sapiens potassium channel tetramerisation domain containing 13 (KCTD13), full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY405827 | KCTD13 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR204825L2V | Lenti ORF particles, Kctd13 (GFP-tagged) - Mouse potassium channel tetramerisation domain containing 13 (Kctd13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204825L1V | Lenti ORF particles, Kctd13 (Myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 13 (Kctd13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||